The bacterial and fungal profiles of patients hospitalized with non-COVID-19 lower respiratory tract infections in Wuhan, China, 2019–2021
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Liangyu Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China. Hauptthemen laut MEDLINE: Respiratory Tract Infections, COVID-19, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
A severe lockdown occurred in Wuhan during the COVID-19 pandemic, followed by a remission phase in the pandemic’s aftermath. This study analyzed the bacterial and fungal profiles of respiratory pathogens in patients hospitalized with non-COVID-19 lower respiratory tract infections (LRTIs) during this period to determine the pathogen profile distributions in different age groups and hospital departments in Wuhan. Methods and results We collected reports of pathogen testing in the medical records of patients hospitalized with non-COVID-19 LRTI between 2019 and 2021. These cases were tested for bacterial and fungal pathogens using 16S and internal transcribed spacer sequencing methods on bronchoalveolar lavage fluid samples. The study included 1368 cases. The bacteria most commonly identified were Streptococcus pneumoniae (12.50%) and Mycoplasma pneumoniae (8.33%). The most commonly identified fungi were Aspergillus fumigatus (2.49%) and Pneumocystis jirovecii (1.75%). Compared to 2019, the S. pneumoniae detection rates increased significantly in 2021, and those of M. pneumoniae decreased. Streptococcus pneumoniae was detected mainly in children. The detection rates of almost all fungi were greater in the respiratory Intensive Care Unit compared to respiratory medicine. Streptococcus pneumoniae and M. pneumoniae were detected more frequently in the pediatric department.
Conclusions
Before and after the COVID-19 outbreak, a change in the common pathogen spectrum was detected in patients with non-COVID-19 in Wuhan, with the greatest change occurring among children. The major pathogens varied by the patient’s age and the hospital department.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
- Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine,Tongji University, Shanghai, 200433, China.
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, 200433, China.
- Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
ORCID-Profile: Ming Wang, Xiaojun Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, L., Zhang, H., Liu, C., Wan, L., Liu, M., Li, R., Liu, H., Yin, J., Shang, M., Luo, Y., Wang, M., & Wu, X. (2024). The bacterial and fungal profiles of patients hospitalized with non-COVID-19 lower respiratory tract infections in Wuhan, China, 2019–2021. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae150
Vancouver
Li L, Zhang H, Liu C, Wan L, Liu M, Li R, et al. The bacterial and fungal profiles of patients hospitalized with non-COVID-19 lower respiratory tract infections in Wuhan, China, 2019–2021. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae150
BibTeX
@article{Li2024,
author = {Li, Liangyu and Zhang, Haiyue and Liu, Chan and Wan, Lu and Liu, Mengling and Li, Ruiyun and Liu, Hailing and Yin, Jing and Shang, Min and Luo, Yuchuan and Wang, Ming and Wu, Xiaojun},
title = {The bacterial and fungal profiles of patients hospitalized with non-COVID-19 lower respiratory tract infections in Wuhan, China, 2019–2021},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae150}
}
EUVIMED